Senior Associate - Project Management

Role Summary Responsible for managing client-sponsored projects from initiation to closure in a CDMO environment. Ensure timely execution, resource coordination, regulatory compliance, and effective communication with sponsors and internal teams. Key Responsibilities Initiation – Update project details in systems, share cost documents, and conduct internal kick-off. Planning – Prepare project charter, risk register, Gantt chart, and communication plan. Execution – Ensure RM procurement, monitor timelines, and coordinate regulatory requirements. Control – Track scope, schedule, and cost; manage risks and change requests. Closure – Capture lessons learned, submit closure report, obtain sponsor acknowledgment, and release team. Eligibility & Education Education: Master’s degree in Pharmacy or Chemistry. Experience: Minimum 2 to 5 years in project management within CDMO or Chemical or pharmaceutical industry. Strong understanding of regulatory requirements and cross-functional coordination. Skills: Proficiency in project management tools (MS Project, Gantt charts) and excel work books. Excellent communication and stakeholder management. Ability to manage budgets, timelines, and risks effectively. Education: Master’s degree in Pharmacy or Chemistry. 📩 Interested candidates may send their CV to: 🔁 Feel free to share or refer suitable candidates in your network. Eurofins Advinus is a premier preclinical and early development CRO offering drug discovery, preclinical and development stage contract research services in the areas of discovery services, regulatory Toxicology (Safety Assessment), DMPK, Analytical R&D Services and API CDMO. Eurofins Advinus manufactures drug substances to support Toxicology and early clinical studies. With over 30 years of GLP compliance and certification, Eurofins Advinus serves diverse industries such as Biotech, Pharmaceutical, Biological, Agrochemical, Nutraceutical and Cosmetic. Eurofins Advinus is the only contract research organization (CRO) in India to have developed data in support of 90+ end-to-end IND enabling packages to be submitted to global regulators such as USFDA, EMA, MHRA, Health Canada and others.